Filing Details
- Accession Number:
- 0001209191-14-043337
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-24 16:37:45
- Reporting Period:
- 2014-06-20
- Filing Date:
- 2014-06-24
- Accepted Time:
- 2014-06-24 16:37:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1578408 | Nick Leschly | C/O Bluebird Bio, Inc. 150 Second Street Cambridge MA 02141 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-06-20 | 17,075 | $40.06 | 355,584 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 15, 2013.
- The range of prices for the transaction reported on this line was $40.00 to $40.42. The average weighted price was $40.0553. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.